Explore All 397 Buyout (LBO, MBO, MBI) Chemicals Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | September 20, 2021 |
| Target | Precision Coating |
| Sector | Chemicals |
| Buyer(s) | Ampersand Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 62 of 86 |
| Sector: Chemicals | 3 of 4 |
| Type: Buyout (LBO, MBO, MBI) | 20 of 23 |
| State: Massachusetts | 14 of 16 |
| Country: United States | 55 of 70 |
| Year: 2021 | 6 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-20 |
N2 Biomedical
Bedford, Massachusetts, United States N2 Biomedical provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 Biomedical was founded in 2013 and is based in Bedford, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-01 |
Biosynth
St. Gallen, Switzerland Biosynth is a fully hybrid research products, life sciences reagents and custom synthesis and manufacturing services company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products. Biosynth was formed in 1965 and is based in St. Gallen, Switzerland. |
Sell | - |
